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The amino acid sequences of the polypeptide chains of the acetylcholine receptor have recently been 
published. From the hydrophilicity profiles, it has been proposed that residues 161-166 of the a-chain 
might be an important antigenic site. We have synthesised a peptide containing this sequence and raised 
antisera to it. Here we report that this peptide does not represent an Important antigenic site on the 
molecule, and that this region is probably inaccessible to antibodies. Based on the known DNA sequences 
and hydrophrhcity profiles of the receptor chains, we suggest hat many regions of high hydrophilicity may 
represent inter-domam regions of proteins. 
Antrgenrc receptor Acetylchokne Hydrophilicity Intron Peptrde 
1. INTRODUCTION 
The nicotinic acetylcholine receptor (nAChR) 
has been the subject of intensive research in recent 
years, not only for its role as a receptor but also as 
the major autoantigen in the human disease, 
myasthenia gravis [l]. The receptor can be readily 
purified to homogeneity from the electric organs 
of fish, such as the ray, Torpedo. The purified 
material consists of 4 different polypeptide chains 
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Abbreviatrons: BOC, tert-butyloxycarbonyl; Bzl, benzyl; 
DCCD, dicyclohexylcarbodiimide; DMF, dimethylfor- 
mamide; Hobt, 1-hydroxybenzotriazole; TEA, triethyl- 
amine; nAChR, nicotinic acetylcholine receptor; BSA, 
bovine serum albumin; RSA, rabbit serum albumin; 
KLH, keyhole limpet haemocyanin; NRS, normal rabbit 
serum; MIR, main immunogenic region; PBS, phos- 
phate-buffered saline (pH 7.1); PBE, PBS containing 
0.1% (w/v) BSA and 1% (v/v) Emulphogen (pH 7.1) 
(cu, 8, y, 6) held together by noncovalent forces [2]. 
Working with a battery of monoclonal antibodies 
to the nAChR of Torpedo calrfornica, authors in 
[3,4] have demonstrated that most antibodies to 
the nAChR are directed to a compact region which 
they call the main immunogenic region (MIR), and 
that these antibodies bind to a certain extent to the 
cu-chain. Recently, the genes for all the chains of T. 
californica and the cu-chain of calf and human 
nAChR have been cloned and sequenced [5-g]. A 
very similar sequence has been obtained for the a- 
chain of the nAChR from another ray, T. mar- 
morata [lo, 111. Extreme conservation of the 
primary structure of the chain is found across these 
different species. Based on the hydrophilicity pro- 
file of the amino acid sequence of the a-chain of 
T. californica, it has been proposed that a region 
consisting of residues 161-166 might correspond 
to the MIR [5,8,9]. We have synthesised a peptide 
containing the sequence 151-169 of the chain of 
Torpedo and here report that this site does not 
represent an important antigenic site on the 
nAChR. 
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2. MATERIALS AND METHODS 
2.1. Synthesis and characterisation of peptide 
151-169 (Tyr-Asp-Gly-Thr-Lys- Val-Ser-lle- 
Ser-Pro-Glu-Ser-Asp-Arg-Pro-Asp-Leu-Ser- 
Thr) 
Boc-L-amino acid derivatives were purchased 
from either Senn Chemicals or Fluka. Side chain 
protecting groups were e-benzyloxycarbonyl group 
for lysine, y and ,&benzyl esters for glutamic and 
aspartic acid, respectively, o-benzyl for serine and 
threonine and finally nitro group for arginine. The 
purity of these derivatives was checked by thin- 
layer chromatography. The standard procedure of 
solid-phase peptide synthesis [12] was modified as 
follows: Firstly, mixing was achieved by flushing 
nitrogen through the reaction vessel; secondly, 
alternate washing with solvents which favour 
swelling (methylene chloride) and extreme shrink- 
ing (methanol) has been favoured [13]. 
The C-terminal residue, Thr(OBzl), was 
esterified to chloromethylated polystyrene (1% 
divinylbenzene) [14] and the substitution was 
found to be 0.30 mmol/g resin on the basis of free 
amino group (upon deblocking of the Boc group) 
determined using prcric acid [ 151. 
The protocol for a typical amino acid coupling 
includes the use of lo-15 ml solvent/g resin (only 
3-5 ml/g for the coupling step) and mixing (Nz 
flushing) for 2 min, unless otherwise specified. (a) 
50% trifluoroacetic acid/CHzClz; (b) 50% 
trifluoroacetic acid/CHzClz, 30 min; (c) CHzClz 
3 x ; (d) CHCls 3 x ; (e) TEA/CHC& (1: 9), 5 min; 
(f) TEA/CHCls (1: 9), 20 min; (g) CHCl3 3 x ; (h) 
CHzClz 3 x ; (i) DMF 2 x ; (j) 8 equiv. Boc amino 
acid and Hobt in DMF; (k) 8 equiv. DCCD in 
CH2C12, 120 min; (1) DMF 3 x ; (m) CHzClz 2 x ; 
(n) CHsOH 3 x ; (0) CHzClz 3 x ; (p) second coupl- 
ing of the same amino acid, steps j-o; (q) 1% ZV- 
acetylimidazole and 10% acetic anhydride in 
CH&lz, 30 min; (r) CHzClz 4 x . Free NH2 groups 
were measured using ninhydrin after each amino 
acid coupling step [16]. 
2.2. Hydrogen fluoride cleavage and deprotectron 
Protected peptide resin (840 mg) was treated 
with 1 ml anisol and about 10 ml anhydrous 
hydrogen fluoride for 1 h at 0°C. Hydrogen 
fluoride was then removed under reduced pressure. 
The resin was washed 3 times with ethyl acetate 
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and the peptide extracted from the resin with 3 
portions (15 ml) of 50% acetic acid and 
lyophilised. 
2.3. Purification 
The crude peptide was dissolved in 0.02 M am- 
monium acetate (pH 6.5) containing 7 M urea and 
applied to a column (0.7 x 26 cm) of 
DEAE-Sephadex A-25 equilibrated with the same 
buffer. A linear gradient elution was performed 
using 200 ml each of 0.02 M and 0.5 M am- 
monium acetate (pH 6.5), containing 7 M urea. 
One major peak appeared in the elution profile 
and was pooled as indicated (fig.l), desalted on 
Sephadex G-10 and lyophilised. 
2.4. Characterlsation 
Amino acid analysis was performed after 
hydrolysis in constant-boiling-point HCl at 110°C 
for 24 h [17]. Descending paper chromatography 
was performed on Whatman 3M paper in 
butanol-acetic acid-water (4 : 1: 5) (organic phase 
only). High-pressure reverse-phase liquid chroma- 
tography was carried out using a gradient of ace- 
tonitrile (O-60% in 80 min) in 0.05% trifluoro- 
acetic acid/0.025% TEA, the flow rate being 
1 .O ml/min. 
2.5. Purification and treatment of nAChR 
The nAChR from T. marmorata was purified as 
in [18] to a specific activity of 6000-10000 pm01 
toxin binding sites/mg protein. Receptor prepara- 
tions were assayed using binding of iodinated cy- 
bungarotoxin [19]. Acid denaturation was per- 
formed by dialysing the receptor for 1 h at 4°C 
against 100 vols of 1 M acetic acid, followed by 
dialysis against PBS. 
2.6. Iodmatlon procedures 
Iodination of the peptide to a specific radioac- 
tivity of 400 Ci/mmol was performed using 
chloramine T. All reagents were in 50 mM 
potassium phosphate buffer (pH 7.0); 10 ,ul of pep- 
tide (5 pg), 10~1 Na1251 (1 mCi) and 10~1 
chloramine T trihydrate (50,~g) were mixed for 
1 min at 22°C. Two hundred ,~l sodium 
metabisulphite (120 fig), 200 ,~l KI (2 mg) and 
500 ~1 buffer containing 1 Vo (w/v) BSA were add- 
ed, and the sample fractionated on a column (0.9 
x 25) of Sephadex G-15 in buffer and 1% BSA. 
Volume 168, number 1 FEBS LETTERS March 1984 
One-ml fractions were collected and the peptide 
peak pooled and stored at 4°C. Iodination of 
the nAChR to a specific radioactivity of 3500 
Ci/mmol with full retention of antigenicity was 
performed as in [20]. Acid-denatured nAChR was 
iodinated by the same method. a-Bungarotoxin 
was labelled to a specific radioactivity of 
900 Ci/mmol [21]. 
2.7. Coupling of peptrde to carrier protem, and 
immunisation protocols 
Peptide was coupled by glutaraldehyde treat- 
ment to the carrier proteins KLH and RSA using 
6 mg peptide and 20 mg protein [22]. Free peptide 
was removed by dialysis. Incorporation of peptide 
was measured using trace-labelled peptide. The 
final conjugates contained 13-15% (w/w) peptide. 
Female New Zealand White rabbits were immun- 
ised intramuscularly with lo-1OOOpg of conju- 
gates at 3 weekly intervals, initially in Freund’s 
complete adjuvant then in incomplete adjuvant. 
Antibodies to the nAChR and acid-denatured 
receptor were raised in rabbits as in [23]. Rat 
monoclonal antibodies 6, 12 and 16 were prepared 
and characterised as in [3]. 
2.8. Antlbody assays 
All assays were performed in PBE. 
2.8.1. Iodinated peptide and anti-nAChR sera 
One hundred,ul of a lOO-fold dilution of test sera 
or NRS was incubated with 50 pl labelled peptide 
(0.86 pmol) for 1 h at 22°C. The complexed 
material was precipitated by incubation with 50 ~1 
of 10% (w/v) Staphylococcus aureus, Cowan 
strain I, in PBE. 
2.8.2. Unlabelled peptide in competition with 
iodinated nAChR 
Fifty ~1 of labelled antigen (nAChR or acid- 
denatured nAChR, 0.1 pmol) was mixed with 50 ~1 
unlabeiled peptide (12 pmol) or buffer, followed 
by 100 pl of test sera or NRS (dilutions of test sera 
were in lOO-fold diluted NRS, the dilution used be- 
ing sufficient to bind one-tenth of the offered 
labelled antigen in the absence of peptide). After 
1 h at 22’C the bound counts were precipitated 
with S. aureus as above. 
2.8.3. Antibodies produced by immunisation with 
peptide conjugate 
One hundred ,ul of diluted test sera or NRS was 
incubated with 50 ~1 labelled peptide (0.86 pmol), 
nAChR (0.1 pmol), acid-denatured receptor 
(0.07 pmol) or SDS-denatured receptor (0.1 pmol) 
for 1 h at 22°C. The bound counts were then pre- 
cipitated using S. aureus. When receptor labelled 
with iodinated toxin was used, excess iodinated 
toxin was incubated with the iodinated receptor for 
1 h at 22”C, prior to use. 
3. RESULTS 
The peptide 151-169 from the sequence of the 
a-chain of Torpedo was synthesised by the solid- 
phase method. The final product showed a single 
spot on descending paper chromatography, and 
essentially a single peak on HPLC (fig.1). The 
amino acid composition was that expected for the 
required sequence: Asp 3.2(3), Ser 4.2(4), Thr 
1.9(2), Glu 1.1(l), Pro 1.9(2), Gly 1.0(l), Val 
1.0(l), Ile 1.0(l), Leu 1.0(l), Tyr 0.9(l), Lys 
1.0(l), Arg 1.0(l). Binding experiments using 
iodinated peptide and antibodies to native and 
denatured receptor (table 1) demonstrated that the 
peptide is recognised only by antibodies to 
Fig.1. Ion-exchange chromatography of synthetic 
peptide 151-169 on a DEAE-Sephadex A-25 column 
(0.7 x 26 cm). See section 2 for experimental conditions. 
Absorbance was monitored at 260 run. The fractions 
comprising the major peak were pooled as indicated, 
desalted on a column (2 x 40 cm) of Sephadex G-10 m 
0.1 M acetic acid and lyophilised. The peptrde was 
loaded on a reverse-phase HPLC column and eluted 
wrth a gradient from 0 to 60% acetonitrile as shown in 
the inset. 
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Table 1 
Binding of iodinated peptide to anti-nAChR sera 
cpm bound 
NRS 
TB7 
Antisera to native nAChR 
TBS TB20 TB22 
Antisera to denatured nAChR 
TB17 TB18 
1056 i 289 1039 f 268 1013 f 269 1165 f 99 1062 f 132 5979 + 427 9592 f 804 
Assays were performed as described in section 2. Results are the mean + SD of 6 determinations 
Table 2 
Binding of different antigens to anti-peptide sera 
Rabbit cpm bound 
Peptide nAChR SDS-denatured nAChR Acid-denatured nAChR 
TB31 54261 1000 537 5658 
TB32 106578 10383 8285 17115 
TB33 7915 483 460 2452 
The assays were performed as described in section 2. The antisera are from rabbits immumsed 
with 100 fig peptide-KLH (TB3,l), 770~~ peptide-KLH (TB32) or 100 tg peptide-RSA 
(TB33). All serum samples are from blood taken 7 days after the third injection. Background 
counts using NRS have been subtracted 
Table 3 
Binding of anti-peptide serum to denatured nAChR 
Iodinated antigen cpm bound 
TB32 TB7 NRS 
(a) Receptor 5502 f 488 58082 f 1390 1298 + 123 
Receptor + toxin 6353 f 372 97950 f 4232 2292 + 324 
(b) Non-absorbed nAChR 17883 f 1998 154127 f 6675 3815 f 142 
Toxin-absorbed nAChR 35890 f 2972 96172 f 4526 8577 f 14 
The assays were performed as described in section 2. Complexes of radrolabelled nAChR and 
radiolabelled toxin were formed as described. Absorption of the nAChR was performed by 
incubating labelled nAChR (500 81, 65 pmol) with a-cobratoxin beads (500~1, 30 nmol 
toxin) for 2 h at 22°C. The results are the mean f SD of 3 determinations 
denatured receptor. Competition experiments bet- 
ween unlabelled peptide and ioclinated receptor for 
a limited amount of anti-nAChR antibodies con- 
firmed this result, and also showed that as much as 
33% of antibodies to denatured receptor recognise 
this peptide (0% block of TB7, TBS, 25% of 
TB17, 33% of TB18). The iodinated peptide also 
did not bind to any of 3 monoclonal antibodies 
directed to the MIR. 
In the converse experiment, antibodies raised 
against the peptide were found to react with pep- 
tide and denatured receptor (table 2). No binding 
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was observed with antisera to carrier protein alone 
(not shown). Binding was also observed with 
receptor which had not been deliberately 
denatured; this however was found to occur only 
with receptor which did not bind iodinated toxin 
and could not bind to an a-cobra toxin resin (table 
3), nor was binding inhibited by incubation of the 
receptor with unlabelled cu-bungarotoxin (12 8 17 + 
264 cpm bound without toxin present, 11893 + 
328 cpm in the presence of a lOOO-fold molar ex- 
cess of toxin), showing that this reaction was ex- 
clusively with denatured receptor in the nAChR 
preparation. 
4. DISCUSSION 
The peptide sequence 161- 166 of the a-chain of 
the nAChR has been proposed as a major antigenic 
site [5,8,9]. We here show that a synthetic peptide 
consisting of residues 15 1 - 169 (this sequence being 
identical in T. californica and T. marmorata) does 
not bind to antibodies to the nAChR, clearly 
demonstrating that this site is not an important an- 
tigenic site on the molecule. Similarly, no binding 
was observed to any of 3 monoclonal antibodies to 
the MIR. These 3 antibodies each bind to slightly 
different regions of the MIR. Two are known to 
bind to the a-chain and all react with mammalian 
nAChRs [3]. It is interesting to note, however, that 
this peptide does represent a major antigenic site 
on the denatured molecule. The postulate that this 
peptide might be important antigenically stems on- 
ly from the hydrophilicity profile of the molecule. 
Authors in [24] suggested that the major 
hydrophilic peak of a molecule is invariably an an- 
tigenic site (not necessarily a major antigenic site). 
Their work was restricted to relatively small solu- 
ble proteins, whereas the receptor is a large 
multichain transmembrane protein. Sequencing of 
the a-chain genes of chicken [25] and human [9] 
nAChR shows that the sequence corresponding to 
peptide 161-166 is interrupted by an intron. Se- 
quences coded by different exons have been sug- 
gested to function as different domains of the 
overall structure [26]. If this were the case, the pep- 
tide in question might easily be located in a cleft 
between two domains, explaining why anti-peptide 
antibodies do not bind to the native receptor. The 
alternative explanation for this would be that the 
anti-peptide antibodies simply do not have the cor- 
rect conformation to bind to native receptor. 
However, production of monoclonal antibodies to 
a number of peptides has demonstrated that as 
many as 63% of anti-peptide antibodies can bind 
to the native protein [27]. We ourselves, using 
polyclonal antisera to another receptor peptide, 
find between 20 and 90% reactivity with intact 
receptor (in preparation). The use of hydrophilic 
peaks as a means of choosing candidates for an- 
tigenic sites in complex proteins must therefore be 
treated with caution. Comparison of the DNA se- 
quence of the genes encoding the chicken [25] and 
human [9] a-chain and chicken y-chain (M. 
Ballivet, personal communication) with the cor- 
responding hydrophilicity profile for the very 
similar sequence from T. californica shows an in- 
variable correspondence between the presence of 
an intron in the DNA and hydrophilic peak in the 
polypeptide sequence. It is conceivable therefore 
that the majority of hydrophilic peaks in such pro- 
teins, rather than representing antigenic sites, 
reflect a more open, hydrophilic region between 
different domains of the protein. 
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